These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9252389)

  • 1. Signaling from G protein-coupled receptors to the c-jun promoter involves the MEF2 transcription factor. Evidence for a novel c-jun amino-terminal kinase-independent pathway.
    Coso OA; Montaner S; Fromm C; Lacal JC; Prywes R; Teramoto H; Gutkind JS
    J Biol Chem; 1997 Aug; 272(33):20691-7. PubMed ID: 9252389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A network of mitogen-activated protein kinases links G protein-coupled receptors to the c-jun promoter: a role for c-Jun NH2-terminal kinase, p38s, and extracellular signal-regulated kinase 5.
    Marinissen MJ; Chiariello M; Pallante M; Gutkind JS
    Mol Cell Biol; 1999 Jun; 19(6):4289-301. PubMed ID: 10330170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming G protein-coupled receptors potently activate JNK (SAPK). Evidence for a divergence from the tyrosine kinase signaling pathway.
    Coso OA; Chiariello M; Kalinec G; Kyriakis JM; Woodgett J; Gutkind JS
    J Biol Chem; 1995 Mar; 270(10):5620-4. PubMed ID: 7890682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor induction of the c-jun promoter by a Rac pathway.
    Clarke N; Arenzana N; Hai T; Minden A; Prywes R
    Mol Cell Biol; 1998 Feb; 18(2):1065-73. PubMed ID: 9448004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum.
    Xie W; Herschman HR
    J Biol Chem; 1996 Dec; 271(49):31742-8. PubMed ID: 8940199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling from G protein-coupled receptors to c-Jun kinase involves beta gamma subunits of heterotrimeric G proteins acting on a Ras and Rac1-dependent pathway.
    Coso OA; Teramoto H; Simonds WF; Gutkind JS
    J Biol Chem; 1996 Feb; 271(8):3963-6. PubMed ID: 8626724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling from G protein-coupled receptors to ERK5/Big MAPK 1 involves Galpha q and Galpha 12/13 families of heterotrimeric G proteins. Evidence for the existence of a novel Ras AND Rho-independent pathway.
    Fukuhara S; Marinissen MJ; Chiariello M; Gutkind JS
    J Biol Chem; 2000 Jul; 275(28):21730-6. PubMed ID: 10781600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-kappa B and TRAF-RAC/CDC42-JNK-c-Jun/ATF2 pathways.
    Min W; Pober JS
    J Immunol; 1997 Oct; 159(7):3508-18. PubMed ID: 9317150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor.
    Xie W; Herschman HR
    J Biol Chem; 1995 Nov; 270(46):27622-8. PubMed ID: 7499226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades.
    Gum R; Wang H; Lengyel E; Juarez J; Boyd D
    Oncogene; 1997 Mar; 14(12):1481-93. PubMed ID: 9136992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28-mediated regulation of the c-jun promoter involves the MEF2 transcription factor in Jurkat T cells.
    Shin HM; Han TH
    Mol Immunol; 1999 Feb; 36(3):197-203. PubMed ID: 10403485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Load-induced transcriptional activation of c-jun in rat myocardium: regulation by myocyte enhancer factor 2.
    Nadruz W; Kobarg CB; Constancio SS; Corat PD; Franchini KG
    Circ Res; 2003 Feb; 92(2):243-51. PubMed ID: 12574153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
    Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
    Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways.
    Pestell RG; Albanese C; Watanabe G; Lee RJ; Lastowiecki P; Zon L; Ostrowski M; Jameson JL
    Mol Endocrinol; 1996 Sep; 10(9):1084-94. PubMed ID: 8885243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway.
    Marinissen MJ; Chiariello M; Gutkind JS
    Genes Dev; 2001 Mar; 15(5):535-53. PubMed ID: 11238375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of c-Jun NH2-terminal kinases in isolated canine gastric parietal cells.
    Nagahara A; Wang L; Del Valle J; Todisco A
    Am J Physiol; 1998 Oct; 275(4):G740-8. PubMed ID: 9756505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity and expression of JNK1, p38 and ERK kinases, c-Jun N-terminal phosphorylation, and c-jun promoter binding in the adult rat brain following kainate-induced seizures.
    Mielke K; Brecht S; Dorst A; Herdegen T
    Neuroscience; 1999; 91(2):471-83. PubMed ID: 10366004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors.
    Yang SH; Galanis A; Sharrocks AD
    Mol Cell Biol; 1999 Jun; 19(6):4028-38. PubMed ID: 10330143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. v-Jun represses c-jun proto-oncogene expression in vivo through a 12-O-tetradecanoylphorbol-13-acetate-responsive element in the proximal gene promoter.
    Hussain S; Kilbey A; Gillespie DA
    Cell Growth Differ; 1998 Aug; 9(8):677-86. PubMed ID: 9716184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of mitogen-activated protein kinases and c-Jun/AP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype in NIH 3T3 fibroblasts.
    Janulis M; Silberman S; Ambegaokar A; Gutkind JS; Schultz RM
    J Biol Chem; 1999 Jan; 274(2):801-13. PubMed ID: 9873019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.